Medvi Tirzepatide Cost vs. Zepbound: What You Really Pay

How much does Medvi tirzepatide cost?

Medvi tirzepatide costs about $280 for the first month. After that, it costs about $400 a month. The price is the same for the daily tablet and the weekly shot, and it does not rise with your dose.

Medvi also sells prepaid plans for the shot. Twelve months cost about $3,590, which works out to about $300 a month. Paid month to month, a first year comes to about $4,670.

Promo links on Medvi's site sometimes lower the first month further. They show no end date, so plan around the regular price. For every Medvi plan and fee, see our Medvi cost breakdown.

Medvi vs. Zepbound: the real price face-off

Zepbound from Lilly costs about $300 a month at 2.5 mg, about $400 at 5 mg and about $450 from 7.5 mg. So Medvi costs more at the starting dose, about the same at 5 mg and about $50 less from 7.5 mg.

Two things narrow or widen that gap. First, Lilly's price is for the medicine only. You also need a prescriber, and a visit may cost extra, while Medvi's price includes its online visit. Second, Zepbound's $450 price needs each refill within 45 days. Late refills cost about $500 at 7.5 mg and about $700 from 10 mg.

Over a first year, Medvi month to month costs about $4,670. Zepbound climbing to 7.5 mg costs about $5,650 for 13 four-week fills, if every fill gets the self-pay price. Lilly's KwikPen terms cap that price at 11 fills a calendar year, and the offer ends Dec 31, 2026.

Skip both programs and Zepbound costs far more. A GoodRx coupon at a retail pharmacy lands around $995 to $1,050 a month, and the list price is about $1,085. For every path, including insurance, see Zepbound cost.

Medvi or Zepbound: which fits your situation?

• You want the FDA-approved drug and pay cash: Zepbound from Lilly, about $300 to $450 a month, cheaper than Medvi below 7.5 mg.
• You expect to reach 7.5 mg or more, and compounded doesn't worry you: Medvi, about $400 a month at every dose. Budget for the regular price, not the first month.
• You have commercial insurance or Medicare: Zepbound only. Neither the savings card nor Medicare's GLP-1 Bridge works with anything Medvi sells.
• You want to avoid needles: Medvi's tablet is the only tirzepatide pill here, but it has no published absorption data. Lilly's FDA-approved pill is Foundayo, a different medicine.
• You want more compounded sellers: see Zepbound vs. compounded tirzepatide.

What are you comparing: Medvi's compounded menu or FDA-approved Zepbound?

Medvi sells compounded tirzepatide as a daily tablet or a weekly shot. It also sells compounded semaglutide in both forms. A separate $99 monthly membership gives access to brand-name Zepbound and Wegovy, with the medicine billed on top.

Zepbound comes only as a shot: a single-dose pen, a KwikPen or a vial. The FDA approved it as a finished drug in 2023.

Compounded means a pharmacy makes the medicine for one patient. It is not reviewed by the FDA the way a finished drug like Zepbound is. Medvi's partner pharmacies are state-licensed and named on its site.

Is Medvi legit and safe compared to Zepbound?

Medvi is a real telehealth service, not a supplement shop. It owns no pharmacy and employs no prescribers. Outside companies, such as OpenLoop Health, provide the licensed clinicians, and partner pharmacies make the medicine.

The FDA has flagged Medvi once. On February 20, 2026, it sent Medvi a warning letter. The letter objected to site wording that its compounded products share "the same active ingredient as" Wegovy, Ozempic, Mounjaro and Zepbound. The FDA sent similar letters to 30 telehealth companies the next month.

Its reputation is mixed. Trustpilot shows 4.3 out of 5 from about 15,000 reviews. ConsumerAffairs shows about 3.3. The Better Business Bureau gives Medvi an F, not accredited, with about 770 complaints in three years and 136 unanswered, mostly about billing and cancellations.

Refunds are strict: a full refund only within 72 hours and before anything ships. For the full audit, see is Medvi legit and our Medvi review.

Is Medvi's compounded tirzepatide as effective as Zepbound?

It has the same active medicine, with a different evidence base. Zepbound's results come from large trials. In SURMOUNT-1, people on 15 mg lost about 21% of their weight over 72 weeks, against about 3% on placebo.

No published trial covers Medvi's own products. The shot travels into the body the same way Zepbound does. The tablet is different: tirzepatide is a peptide that digestion breaks down, and no human data show how much of a compounded tablet reaches the blood.

Is compounded tirzepatide from Medvi still legal?

Yes, on a narrow basis. The FDA ended the tirzepatide shortage in December 2024, which ended mass compounding. A licensed pharmacy can still make tirzepatide for one patient on a prescription.

On April 30, 2026, the FDA proposed not adding tirzepatide, semaglutide and liraglutide to the list that large outsourcing pharmacies, called 503B, can compound from. Comments closed July 30, 2026, with no final decision yet. Zepbound vs. compounded tirzepatide covers the legal picture.

Does insurance or a savings card work with either?

Not with Medvi. Compounded medicine is cash only, with no insurance billing and no maker's savings card.

Zepbound has two paths to a lower price. If your commercial plan covers Zepbound, Lilly's savings card can bring a fill to as little as $25 a month. On Medicare, the GLP-1 Bridge charges $50 a month for the Zepbound KwikPen from July 1, 2026 to December 31, 2027. It has BMI and health rules and excludes people with type 2 diabetes.